Bellicum Pharmaceuticals, Inc. EBITDA Margin 2015-2023 | BLCM
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bellicum Pharmaceuticals, Inc. (BLCM) over the last 10 years. The current EBITDA margin for Bellicum Pharmaceuticals, Inc. as of September 30, 2023 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2023-09-30 |
$0.00B |
$-0.02B |
-1200.00% |
2022-09-30 |
$0.00B |
$-0.03B |
-1250.00% |
2019-12-31 |
$0.01B |
$-0.08B |
-1128.57% |
2019-09-30 |
$0.00B |
$-0.09B |
-4600.00% |
2019-06-30 |
$0.00B |
$-0.09B |
-4600.00% |
2019-03-31 |
$0.00B |
$-0.09B |
-9000.00% |
2018-12-31 |
$0.00B |
$-0.09B |
inf% |
2018-09-30 |
$0.00B |
$-0.08B |
inf% |
2018-06-30 |
$0.00B |
$-0.08B |
inf% |
2017-12-31 |
$0.00B |
$-0.08B |
inf% |
2017-09-30 |
$0.00B |
$-0.08B |
inf% |
2017-03-31 |
$0.00B |
$-0.07B |
inf% |
2016-12-31 |
$0.00B |
$-0.07B |
inf% |
2016-09-30 |
$0.00B |
$-0.06B |
inf% |
2016-06-30 |
$0.00B |
$-0.06B |
inf% |
2016-03-31 |
$0.00B |
$-0.05B |
inf% |
2015-12-31 |
$0.00B |
$-0.05B |
inf% |
2015-09-30 |
$0.00B |
$-0.08B |
inf% |
2015-06-30 |
$0.00B |
$-0.07B |
-7000.00% |
2015-03-31 |
$0.00B |
$-0.06B |
-3150.00% |
2014-12-31 |
$0.00B |
$-0.06B |
-1900.00% |